eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | metabolic syndrome x |
| Symptom | |vascular disease |
| Sentences | 67 |
| PubMedID- 20609696 | In addition, hypertension is an important contributor to increasing cardiovascular disease risk in patients with the cardiometabolic syndrome. |
| PubMedID- 19781706 | There is ample epidemiological evidence linking obesity, and the related ‘metabolic syndrome’, with vascular disease 1. |
| PubMedID- 21122628 | Background: metabolic syndrome is associated with increased cardiovascular disease (cvd) risk, a risk that is significantly increased when accompanied by elevated low-density lipoprotein cholesterol (ldl-c). |
| PubMedID- 20509277 | Aim: to analyze the components of metabolic syndrome from patients with cardiovascular disease (myocardial infarction). |
| PubMedID- 24453423 | Importantly also, whereas consistent disparities in the associations of cardiovascular risk factors including crp concentrations, blood pressure, lipid levels, obesity and metabolic syndrome with cardiovascular disease in black compared to white african patients with ra were recently identified by us , ethnicity did not impact the il-6-endothelial activation relationship in the present investigation. |
| PubMedID- 24624345 | Moreover, many epidemiological studies have suggested that hyperuricemia, which may be an independent risk factor for metabolic syndrome , cerebrovascular disease 6, obesity, diabetes, hypertriglyceridemia, and hypertension. |
| PubMedID- 22760893 | Os is associated with endothelial dysfunction and metabolic syndrome, which leads to cardiovascular diseases. |
| PubMedID- 24708775 | In clinical trials, bezafibrate has been highly effective at reducing cardiovascular disease risk in patients with metabolic syndrome or atherogenic dyslipidemia . |
| PubMedID- 22121272 | Although metabolic syndrome leads to cardiovascular disease, psoriasis might be an independent risk factor for hypertension and cardiovascular disease even after correction for metabolic syndrome components. |
| PubMedID- 22321049 | Metabolic disorders such as arterial hypertension (ah), hypercholesterolemia, diabetes mellitus (dm), high triglycerides (tg), abdominal obesity, and metabolic syndrome (mets) are associated with cardiovascular disease (cvd) and cvd-related mortality. |
| PubMedID- 25247821 | These findings have important public health implications due to the known cardiovascular disease risk factors associated with metabolic syndrome. |
| PubMedID- 22916265 | The higher risk of cardiovascular disease in patients with metabolic syndrome and hypertension could depend partly on the degree of sympathetic hyperactivity. |
| PubMedID- 24676221 | Background: subclinical cardiovascular disease is prevalent in patients with metabolic syndrome (metsyn). |
| PubMedID- 26525819 | Thus, primary and secondary prevention of cerebrovascular disease in patients with metabolic syndrome should include haemangiocorrective, antithrombotic, antioxidant and endothelium-protective treatment, as well as therapy of the main components of metabolic syndrome. |
| PubMedID- 26491696 | In particular, sodium reabsorption is regulated by various transporters along the nephron and to elucidate the mechanism of its regulation is important because excess renal sodium retention causes hypertension in metabolic syndrome that leads to cardiovascular disease 1. |
| PubMedID- 25918936 | The molecular processes that occur in metabolic syndrome can lead to cardiovascular disease pathogenesis and involve risk factors such as oxidative stress and inflammation . |
| PubMedID- 24844874 | Background: subclinical cardiovascular disease is prevalent in patients with metabolic syndrome (metsyn). |
Page: 1 2